CD4 and graft versus host disease: Multiple approaches have attempted to separate GVHD and GVT responses (reviewed in ref. 1), including limiting Th1 responses (52), blocking inflammatory cytokines (e.g., TNF-α) (53), and differentially impacting CD4+ or CD8+ responses (54–56).